Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MAYNF MAYNE PHARMA GROUP LIMITED

Watchlist
0.185
-0.002-1.07%
Trading Session 11/28 13:26 ET
High
0.205
Open
0.205
Turnover
1.41K
Low
0.185
Pre Close
0.187
Volume
6.90K
Market Cap
321.87M
P/E(TTM)
Loss
52wk High
0.293
Shares
1.74B
P/E(Static)
Loss
52wk Low
0.150
Float Cap
321.87M
Bid/Ask %
0.00%
Historical High
0.384
Shs Float
1.74B
Volume Ratio
1.70
Historical Low
0.150
Dividend TTM
--
Div Yield TTM
--
P/B
0.84
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
10.60%
Avg Price
0.204
Lot Size
1
Float Cap
321.87M
Bid/Ask %
0.00%
Historical High
0.384
Shs Float
1.74B
Volume Ratio
1.70
Historical Low
0.150
Dividend TTM
--
P/B
0.84
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
10.60%
Avg Price
0.204
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
CEO: Mr. Shawn Patrick O’Brien
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist